Efficacy and safety of regdanvimab in patients with mild/moderate COVID-19 and high risk of progression of the disease: a retrospective study in a short-term stay unit - PDF (Russian)
Copyright (c) 2022 Consilium Medicum
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.